참고문헌
- Bai L, Merchant JL (2007). A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion. FEBS Letters, 581, 5904-10. https://doi.org/10.1016/j.febslet.2007.11.072
- Barbetti V, Gozzini A, Cheloni G, et al (2013). Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells. Epigenetics, 8, 210-9. https://doi.org/10.4161/epi.23538
-
Chen W-Q, Xu B, Mao J-W, et al (2014). Inhibitory effects of
$\alpha$ -pinene on hepatoma carcinoma cell proliferation. Asian Pac J Cancer Prev, 15, 3293-7. https://doi.org/10.7314/APJCP.2014.15.7.3293 -
Cui J, Zhou X, Liu Y, et al (2001). Mutation and overexpression of the
$\beta$ -catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people. J Cancer Res Clin Oncol, 127, 577-81. https://doi.org/10.1007/s004320100259 -
Dahmani R, Just PA, Perret C (2011). The Wnt/
$\beta$ -catenin pathway as a therapeutic target in human hepatocellular carcinoma. Clin Res Hepatol Gastroenterol, 35, 709-13. https://doi.org/10.1016/j.clinre.2011.05.010 -
Debeb BG, Lacerda L, Xu W, et al (2012). Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT/
$\beta$ -catenin signaling. Stem Cells, 30, 2366-77. https://doi.org/10.1002/stem.1219 - Feng D, Wu J, Tian Y, et al (2013). Targeting of histone deacetylases to reactivate tumour suppressor genes and its therapeutic potential in a human cervical cancer xenograft model. PLoS One, 8, 80657-68. https://doi.org/10.1371/journal.pone.0080657
- Fujisawa K, Maesawa C, Sato R, et al (2005). Epigenetic status and aberrant expression of the maspin gene in human hepatobiliary tract carcinomas. Lab Invest, 85, 214-24. https://doi.org/10.1038/labinvest.3700214
- Haghshenas MR, Arabi M, Mousavi T (2014). Hepatitis B genotypes in iran. Mater Sociomed, 26, 129-33. https://doi.org/10.5455/msm.2014.26.129-133
- Herold C, Ganslmayer M, Ocker M, et al (2002). The histonedeacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells. J Hepatol, 36, 233-40.
-
Iguchi H, Urashima Y, Inagaki Y, et al (2007). SOX6 suppresses cyclin D1 promoter activity by interacting with
$\beta$ -catenin and histone deacetylase 1, and its down-regulation induces pancreatic$\beta$ -cell proliferation. J Biol Chem, 282, 19052-61. https://doi.org/10.1074/jbc.M700460200 - Ji Z, Wang T, Shao Z, et al (2014). A population-based study examining hepatitis B virus infection and immunization rates in Northwest China. PLoS One, 9, 97474-84. https://doi.org/10.1371/journal.pone.0097474
- Ker CG, Chen JS, Kuo KK, et al (2011). Liver surgery for hepatocellular carcinoma: laparoscopic versus open approach. Int J Hepatol, 2011, 596792.
- Lazarova DL, Bordonaro M, Carbone R, et al (2004). Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate. Int J Cancer, 110, 523-31. https://doi.org/10.1002/ijc.20152
- Lee JE, Bae SH, Choi JY, et al (2014). Epirubicin, cisplatin, 5-FU combination chemotherapy in sorafenib-refractory metastatic hepatocellular carcinoma. World J Gastroenterol, 20, 235-41. https://doi.org/10.3748/wjg.v20.i1.235
- Li J-P, Cao N-X, Jiang R-T, et al (2014). Knockdown of GCF2/LRRFIP1 by RNAi causes cell growth inhibition and increased apoptosis in human hepatoma HepG2 cells. Asian Pac J Cancer Prev, 15, 2753-8. https://doi.org/10.7314/APJCP.2014.15.6.2753
- Marks P, Rifkind RA, Richon VM, et al (2001). Histone deacetylases and cancer: causes and therapies. Nat Rev Cancer, 1, 194-202. https://doi.org/10.1038/35106079
- Miyahara K, Nouso K, Yamamoto K (2014). Chemotherapy for advanced hepatocellular carcinoma in the sorafenib age. World J Gastroenterol, 20, 4151-9. https://doi.org/10.3748/wjg.v20.i15.4151
-
Miyoshi H, Deguchi A, Nakau M, et al (2009). Hepatocellular carcinoma development induced by conditional
$\beta$ -catenin activation in Lkb1+/- mice. Cancer Sci, 100, 2046-53. https://doi.org/10.1111/j.1349-7006.2009.01284.x - Mosimann C, Hausmann G, Basler K (2009). Beta-catenin hits chromatin: regulation of Wnt target gene activation. Nat Rev Mol Cell Biol, 10, 276-86. https://doi.org/10.1038/nrm2654
- Myzak MC, Karplus PA, Chung FL, et al (2004). A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res, 64, 5767-74. https://doi.org/10.1158/0008-5472.CAN-04-1326
- Osaki A, Suda T, Kamimura K, et al (2013). A safe and effective dose of cisplatin in hepatic arterial infusion chemotherapy for hepatocellular carcinoma. Cancer Med, 2, 86-98. https://doi.org/10.1002/cam4.55
- Page AJ, Cosgrove DC, Philosophe B, et al (2014). Hepatocellular carcinoma: diagnosis, management, and prognosis. Surg Oncol Clin N Am, 23, 289-311. https://doi.org/10.1016/j.soc.2013.10.006
- Pathil A, Armeanu S, Venturelli S, et al (2006). HDAC inhibitor treatment of hepatoma cells induces both TRAILindependent apoptosis and restoration of sensitivity to TRAIL. Hepatology, 43, 425-34. https://doi.org/10.1002/hep.21054
- Quint K, Agaimy A, Di Fazio P, et al (2011). Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC. Virchows Arch, 459, 129-39. https://doi.org/10.1007/s00428-011-1103-0
- Scaggiante B, Kazemi M, Pozzato G, et al (2014). Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials. World J Gastroenterol, 20, 1268-88. https://doi.org/10.3748/wjg.v20.i5.1268
-
Shao N, Zou J, Li J, et al (2012). Hyper-activation of WNT/
$\beta$ -catenin signaling pathway mediates anti-tumor effects of histone deacetylase inhibitors in acute T lymphoblastic leukemia. Leuk Lymphoma, 53, 1769-78. https://doi.org/10.3109/10428194.2012.663085 - Song W-F, Wang L, Huang W-Y, et al (2013). MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells. Asian Pac J Cancer Prev, 14, 7529-36. https://doi.org/10.7314/APJCP.2013.14.12.7529
- Tanase A-M, Dumitrascu T, Dima S, et al (2014). Influence of hepatitis viruses on clinico-pathological profiles and long-term outcome in patients undergoing surgery for hepatocellular carcinoma. Hepatobiliary Pancreatic Dis Int, 13, 162-72. https://doi.org/10.1016/S1499-3872(14)60026-6
-
Thompson MD, Monga SP (2007). WNT/
$\beta$ -catenin signaling in liver health and disease. Hepatology, 45, 1298-305. https://doi.org/10.1002/hep.21651 - Tsai WL, Lai KH, Liang HL, et al (2014). Hepatic arterial infusion chemotherapy for patients with huge unresectable hepatocellular carcinoma. PLoS One, 9, 92784. https://doi.org/10.1371/journal.pone.0092784
- Venturelli S, Armeanu S, Pathil A, et al (2007). Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma. Cancer, 109, 2132-41. https://doi.org/10.1002/cncr.22652
- Wiltse J (2005). Mode of Action: Inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin-developmental effects of valproic acid. Crit Rev Toxicol, 35, 727-38. https://doi.org/10.1080/10408440591007403
- Woo HJ, Lee SJ, Choi BT, et al (2007). Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. Exp Mol Pathol, 82, 77-84. https://doi.org/10.1016/j.yexmp.2006.02.004
- Xu L-B (2010). Staging systems for predicting survival of patients with hepatocellular carcinoma after surgery. World Journal of Gastroenterology, 16, 5257. https://doi.org/10.3748/wjg.v16.i41.5257
- Yang XJ, Seto E (2007). HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene, 26, 5310-8. https://doi.org/10.1038/sj.onc.1210599
-
Ying Y, Tao Q (2009). Epigenetic disruption of the WNT/
$\beta$ -catenin signaling pathway in human cancers. Epigenetics, 4, 307-12. https://doi.org/10.4161/epi.4.5.9371 - Zhang Q-C, Jiang S-J, Zhang S, et al (2012). Histone deacetylase inhibitor trichostatin a enhances antitumor effects of docetaxel or erlotinib in A549 cell line. Asian Pac J Cancer Prev, 13, 3471-6. https://doi.org/10.7314/APJCP.2012.13.7.3471
피인용 문헌
- Clinical significance of STAT3 and MAPK phosphorylation, and the protein expression of cyclin D1 in skin squamous cell carcinoma tissues vol.12, pp.6, 2012, https://doi.org/10.3892/mmr.2015.4460
- Differentially Expressed Genes in Metastatic Advanced Egyptian Bladder Cancer vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3543
- Clinical significance of the phosphorylation of MAPK and protein expression of cyclin D1 in human osteosarcoma tissues vol.15, pp.4, 2017, https://doi.org/10.3892/mmr.2017.6224
- Short hairpin RNA silencing of TGF-βRII and FZD-7 synergistically suppresses proliferation and metastasis of hepatocellular carcinoma cells vol.11, pp.3, 2016, https://doi.org/10.3892/ol.2016.4208